MIR6766

Across TCGA pan-cancer cohorts, MIR6766 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR6766 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MIR6766 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6766 expression acts as an unfavorable survival marker, although some lineages such as CESC and STAD show a favorable association.

SKCM, CESC, and KIRC are the cancer types where MIR6766 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	IV	0.179	0.755	<.001	39	view →
CESC	OS	Tertile	All	1.000	0.552	.012	36	view →
KIRC	DFS	Tertile	IV	0.108	0.660	<.001	30	view →
OV	OS	Tertile	III,IV	0.781	0.845	.014	30	view →
GBM	DFS	Tertile	All	0.087	0.264	<.001	27	view →
LIHC	DFS	Tertile	All	0.080	0.553	.004	27	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
TGCT	OS	Tertile	All	0.845	0.968	.017	18	view →
KIRP	DFS	Tertile	II,III,IV	0.433	0.790	.032	18	view →
STAD	OS	Tertile	All	0.657	0.542	.034	10	view →
DLBC	DFS	Tertile	III,IV	0.137	0.761	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR6766–SKCM (OS)

Open the SKCM breakdown →